HERAX
Price
$10.69
Change
+$0.22 (+2.10%)
Updated
May 12 closing price
Net Assets
402.49M
VEMRX
Price
$99.71
Change
+$2.50 (+2.57%)
Updated
May 12 closing price
Net Assets
112.08B
Ad is loading...

HERAX vs VEMRX

Header iconHERAX vs VEMRX Comparison
Open Charts HERAX vs VEMRXBanner chart's image
Hartford Emerging Markets Equity A
Price$10.69
Change+$0.22 (+2.10%)
VolumeN/A
Net Assets402.49M
Vanguard Emerging Mkts Stock Idx InsPlus
Price$99.71
Change+$2.50 (+2.57%)
VolumeN/A
Net Assets112.08B
HERAX vs VEMRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HERAX vs. VEMRX commentary
May 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HERAX is a Sell and VEMRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEMRX has more cash in the bank: 112B vs. HERAX (402M). VEMRX pays higher dividends than HERAX: VEMRX (3.14) vs HERAX (2.56). HERAX was incepted earlier than VEMRX: HERAX (14 years) vs VEMRX (14 years). HERAX (1.54) is less costly to investors than VEMRX (0.07). HERAX is a more actively managed with annual turnover of: 113.00 vs. VEMRX (8.00). HERAX has a lower initial minimum investment than VEMRX: HERAX (2000) vs VEMRX (100000000). HERAX annual gain was more profitable for investors over the last year : 9.19 vs. VEMRX (8.67). HERAX return over 5 years is better than : 56.69 vs. VEMRX (41.67).
HERAXVEMRXHERAX / VEMRX
Total Expense Ratio1.450.072,071%
Annual Report Gross Expense Ratio1.540.072,200%
Fund Existence14 years14 years-
Gain YTD5.4384.600118%
Front Load6%N/A-
Min. Initial Investment20001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets402M112B0%
Annual Yield % from dividends2.563.1482%
Returns for 1 year9.198.67106%
Returns for 3 years29.9719.94150%
Returns for 5 years56.6941.67136%
Returns for 10 years40.0524.69162%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHSCX47.73N/A
N/A
BlackRock Health Sciences Opps Inv C
PMDAX17.61N/A
N/A
Principal Small-MidCap Dividend Inc A
IHSSX23.21N/A
N/A
Hartford Small Company R4
OSTVX16.03N/A
N/A
Osterweis Growth & Income Fund
AFGZX28.46N/A
N/A
Alger Global Equity Z